Elizabeth Tanner

This is Part 3 in a three-part series on key factors in CRO selection. (Check out Part 1 and Part 2). Use of CROs in research and drug development...

This is Part 2 in a three-part series on key factors in CRO selection. (Check out Part 1 and Part 3). Contract research organizations (CROs) often...

Successful life science startup entrepreneurs share the basics on starting a business. Aspiring entrepreneurs received advice from an optimistic...

Cell culture is the foundation of high throughput screening during drug development. However, it is well known that there is a big and precarious...

This is Part 1 in a three-part series on key factors in CRO selection. (Check out Part 2 and Part 3). Alternative strategies for approaching drug...

Amidst the many challenges facing the life sciences industry today such as diminishing funding sources, increased costs to develop new drugs and...